NewImage

Check out this weeks episode of Talent Talks on YouTube and Spotify! This week we sit with Richard Bendis President and CEO of BioHealth Innovation, Inc. He talks about the importance of knowing your assets and the region around you with our hosts Robb Hoyle CEO GTS Scientific and Gregory Hoyle. Click below to watch and make sure to like and subscribe: https://hubs.li/H0JRgfF0

CN Master RGB HiRes Lg

WASHINGTON, March 23, 2021 /PRNewswire/ -- Congenital heart disease (CHD) affects six out of 1,000 babies born in the U.S. each year and is often complicated by arrhythmias, a condition where the heart beats too rapidly, too slowly or irregularly due to a misfiring of the body's electrical impulses. While the last decade brought great advances in technologies that improve the care of adult arrhythmias, pediatric patients have been left behind, with only five devices approved for use in children in the same period. As a result, pediatric specialists are often using off-label or improvised devices to treat pediatric arrhythmias, including in the smallest newborns.

 

Novavax Logo

When Novavax Inc. received $1.6 billion last year from the federal government to speed up testing and production of a coronavirus vaccine, some observers were incredulous. The small biotechnology firm, based in Gaithersburg, Maryland, was largely unknown and had never successfully brought a product to market.

But now that the company nears completion of its Phase 3 trials for its COVID-19 vaccine, which was found to be nearly 90% effective during clinical testing in the United Kingdom, it is grabbing headlines around the world.

 

Tedco Application Request Logo

COLUMBIA, Md. (March 25, 2021) –TEDCO, Maryland’s economic engine for technology companies, announced today its request for applications for the Agriculture and Rural Rebuild (ARR) Challenge, created to assist Maryland’s rural and agricultural businesses that have been detrimentally impacted by the COVID-19 pandemic and associated economic downturn. TEDCO will award grants up to $200,000 per project. 

“The ARR Challenge encourages purposeful collaboration between rural businesses, research institutions and industry partners,” stated Dr. Arti Santhanam, MII executive director. “Examples of a successful project may include, but is not limited to, the development of an innovative product or a novel application of an existing technology applicable to agriculture or other rural industry sectors.” 

 

neoummunetech logo

ROCKVILLE, Md.–(BUSINESS WIRE)–NeoImmuneTech, Inc. (KOSDAQ: 950220), a clinical-stage T cell-focused biopharmaceutical company, today announced the closing of its initial public offering of 3,133,334 shares of common stock, equivalent with 15,666,670 Korea Depository Receipts (KDRs) priced at KRW 37,500 per share, equivalent with KRW 7,500 per KDRs. The aggregate gross proceeds to NeoImmuneTech, before deducting underwriting discounts and commissions and other offering expenses, were KRW 117.5 billion ($103.4 million). NeoImmuneTech’s common stock began trading on the Korea Exchange on March 16, 2021, under the KOSDAQ code number “950220.”

 

NewImage

Our AstraZeneca Gaithersburg Campus will be illuminated this week to pay tribute to José Baselga, our beloved Oncology R&D leader and Site Head who passed away last weekend. Our entire community is devasted by this unexpected news following a period of temporary medical leave that he began in January 2021. An outstanding scientific leader, José leaves a lasting legacy in the scientific community and especially here at AstraZeneca Gaithersburg. He set our Oncology R&D function on a remarkable trajectory, and his visionary leadership, deep scientific expertise and strategic insight have delivered so many achievements that will benefit patient lives in the years to come. The blue and garnet lights were chosen to celebrate his favorite hometown soccer club, FC Barcelona. He will be deeply missed across our campus, and we will continue to be inspired by his work and vison.

For any inquiries please reach out to Joe Sanchez at joseph.sanchez @astrazeneca.com.

MCEDC Logo

Rockville, Md. — The Montgomery County Economic Development Corporation (MCEDC) awarded a total of $96,430 to six small life science companies as part of its recently completed Bio Lab Pilot Project. The project was launched in 2019 to assist local growth-stage life science companies with their wet lab and infrastructure needs. Applicants seeking financial help to build out small wet lab space less than 5,000 SF were encouraged to apply for $10 per SF of lab fit out costs, up to $30,000 per company. Project funding was provided by MCEDC and the Maryland Department of Commerce. 

 

Precigen Logo

GERMANTOWN, Md., March 23, 2021 /PRNewswire/ -- Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that the first patient has been dosed in the Phase I study of PRGN-2012, a first-in-class, investigational off-the-shelf (OTS) AdenoVerse™ immunotherapy in adult patients with recurrent respiratory papillomatosis (RRP) (clinical trial identifier: NCT04724980). The US Food and Drug Administration recently granted Orphan Drug Designation for PRGN-2012 in RRP in March 2021.

PRGN-2012 is an innovative therapeutic vaccine with optimized antigen design that uses Precigen's gorilla adenovector technology, part of Precigen's proprietary AdenoVerse platform, to elicit immune responses directed against cells infected with HPV 6 or HPV 11. Gorilla adenovectors have numerous advantages, including the ability for repeat administration, the inability to replicate in vivo, which may improve safety, and the ability to deliver large payload capacity. In preclinical models, PRGN-2012 has demonstrated strong and specific immune response against HPV 6 and HPV 11.

 

Rich Bendis

“Who do you know that others need to know?

We are always one conversation away from changing our lives, and Rich Bendis of BioHealth Innovations started the BioTalk podcast to connect the world of biohealth better.

In a world where medical science advances are growing at the fastest pace in human history, we can still run into a problem where the people who know each other don’t get connected to advance therapy, new medicine, or new approaches.”

Key Topics:

What is the goal of Biohealth Innovations (1:44)

How has the medical research changed as a result of COVID (3:24)

How was the COVID vaccine researched (8:06)

What made podcasting the right next step for BioHealth (10:22)

Who has benefited from the podcast (12:29)

 

Visit https://causepods.org/podcast/the-more-we-know-with-rich-bendis-of-the-biotalk-podcast/ to listen.

NewImage

BIoHealth Innovation is sad to hear of the passing of Jose Basegla, the Head of the ASTRA Zeneca Oncology R&D business and the Gaithersburg Site Head.
Jose was a strong proponent for making the BIoHealth Capital Region a leading BIoHealth hub with a connected ecosystem. AZ was also a founding member of BIoHealth Innovation and continues to support us today.

An outstanding scientific leader, José leaves a lasting legacy in the scientific community and here at AstraZeneca. He set our Oncology R&D function on a remarkable trajectory, and his visionary leadership, deep scientific expertise and strategic insight have delivered so many achievements that we can all be proud of and that will benefit patients’ lives in the years to come.

 

Childrens Hospital Coalition

RICHMOND, Va., March 18, 2021 – Phlow Corp., a U.S.-based, public benefit corporation committed to a bold mission of providing every American with access to affordable, high-quality essential medicines, today joins in announcing the launch of a groundbreaking Children’s Hospital Coalition: Powered by PhlowTM (CHC). This first-in-kind coalition brings together some of the top children’s hospitals across the nation, in collaboration with Phlow, to provide certainty in availability and access for key medicines necessary to sustain life and conquer disease and to address the nation’s broken essential medicines supply chain.

 

SBIRXL6

More than 160 entrepreneurs attended last week’s BHI Virtual Non-Dilutive Funding Workshop with 1:1 Partnering cohosted by BioHealth Innovation and Montgomery County Economic Development Corporation (MCEDC). Attendees learned about funding opportunities, resources and best practices from program officers at NIH, NSF and the University of Maryland, and also about additional resources and tips for winning applications from experts at MCEDC, the City of Gaithersburg, Maryland Department of Commerce, and BioHealth Innovation. More than 460 partnering meetings were requested. Many took place during the event last week, and others will happen in the near future. Most of the panelists have agreed to share their presentations and panel recordings. These will be available through BHI within the next two weeks. BHI would like to thank the participants who took the time to prepare, present, and/or partner at the event. They include:

  • Henry Ahn - Program Director, National Science Foundation (NSF)
  • Lynne Stein Benzion – Director, Economic Development, Montgomery County Econ. Dev. Corp. (MCEDC)
  • Katie Bratlie - Program Director, National Science Foundation (NSF)
  • Christie Canaria, PhD - Program Director, SBIR Development Center, National Cancer Institute (NCI)
  • Judy Costello – Managing Director, Economic Development, BioHealth Innovation (BHI)
  • Stephanie Davis, PhD - Small Business Program Coordinator, NIH Nat’l Heart Lung & Blood Inst. (NHLBI)
  • Sharon DisqueEconomic Development Manager, City of Gaithersburg, Maryland
  • Stephanie Fertig, HHS Small Business Program Lead, National Institutes of Health (NIH)
  • Jonathan Franca-Koh, PhD - Program Director, SBIR Development Center, National Cancer Inst (NCI).
  • Armineh Ghazarian - Senior Program Analyst, NIH National Institute on Aging (NIA)
  • Colleen Gibney, SBIR Deputy Project Manager, US Army Medical Research & Dev. Command (USAMRDC)
  • Luis Gutierrez - Entrepreneur-in-Residence, BioHealth Innovation, Inc. (BHI)
  • Todd Haim, PhD - Chief, Office of Small Business Research, NIH National Institute on Aging (NIA)
  • Elena Koustova, PhD, MBA - Director, Office of Translational Initiatives and Program Innovations (OTIPI), NIDA SBIR/STTR Coordinator, NIH National Institute of Drug Abuse (NIDA) Office of Director
  • Ashwin Kulkarni, COO, miRecule; Associate, BioHealth Innovation, Inc. (BHI)
  • Natalia Kruchinin, PhD SBIR/STTR Program Coordinator, RTSP, DEA, National Institute of Allergy and Infectious Diseases
  • Carla MerrittSenior Business Development Representative, Maryland Department of Commerce
  • JR Myers, SBIR Project Manager, US Army Medical Research & Development Command (USAMRDC)
  • Mike MinicozziPhD, Senior Program Officer, DAIT, National Institute of Allergy and Infectious Diseases
  • Alastair Monk - Program Director, National Science Foundation (NSF)
  • Deepa Narayanan - Program Director and Team Lead, NIH National Cancer Institute SBIR Development Center (NCI)
  • Rini Pek, PhD - Senior Analyst, BioHealth Innovation, Inc. (BHI)
  • Erik Pierstorff - Program Director, National Science Foundation (NSF)
  • Victor Prikhodko - Senior Business Dev. Mgr., SBIR/STTR NIH National Inst. of Drug Abuse (NIDA)
  • Monique Pond, PhD - Program Director, SBIR Development Center, National Cancer Institute
  • Reema Railkar, PhD Program Manager, SBIR Development Center, National Cancer Institute
  • Saroj Regmi, PhD - Health Science Administrator, Office of Small Business Research, NIH National Institute on Aging
  • Andrea Renner - Technical Assistance Advocate, US Army Medical Research & Dev Command (USAMRDC)
  • Ethel Rubin, PhD - Entrepreneur-in-Residence, BioHealth Innovation, Inc. (BHI)
  • Anthony Saleh, PhD – CEO, miRecule
  • Ben Schrag,PhD - Program Director, National Science Foundation (NSF)
  • John Sullivan - Entrepreneur-in-Residence, BioHealth Innovation, Inc. (BHI)
  • Onur UnalManager, Life Sciences Projects, Maryland Industrial Partnerships (MIPS), Maryland Technology Enterprise Institute (MTech), University of Maryland

 Register (no fee) today!    www.tinyurl.com/2021SBIR  Questions: This email address is being protected from spambots. You need JavaScript enabled to view it.
NOTE:  Different institutes are available to meet at different times during the March 17-19th period. 
              You will be able to request meetings once you have registered and received the partnering log-in.

Register Now!

Click here to view the agenda.

vaccitech logo

OXFORD, United Kingdom, March 17, 2021 (GLOBE NEWSWIRE) -- Vaccitech Ltd (“Vaccitech”), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer, today announces that it has raised $168 million in a Series B financing. This includes $43 million in convertible loan notes previously issued by Vaccitech that converted into Series B shares.

The Series B financing round was led by M&G Investment Management (part of M&G plc), with further participation from new investors including Tencent, Gilead Sciences, Monaco Constitutional Reserve Fund, and Future Planet Capital among others. The Series B financing round was also supported by existing investors, including Oxford Sciences Innovation.

 

AstraZeneca Logo

AstraZeneca announced on Monday that its vaccine was 79 percent effective in preventing symptomatic COVID-19 in Phase III U.S. testing with no safety concerns found.

The company said in a statement that the vaccine was also found to be 100 percent effective in preventing serious cases of the disease and hospitalizations.

AstraZeneca said it will submit the findings to the Food and Drug Administration in a bid for emergency use authorization in the U.S.

 

NewImage

Blacksburg, VA – March 18, 2021 -- The Virginia Tech Corporate Research Center (VTCRC) in partnership with the Virginia Tech Foundation (VTF) has been awarded a grant from the GO Virginia program to fund the evaluation and design of new lab concepts to serve southwest Virginia’s growing life and health sciences industry. The award is part of the Enhanced Capacity Building program that will support Virginia’s Region 2.

“We’re honored to be selected to lead this project. The VTCRC is dedicated to making flexible lab space more accessible for smaller startups as well as some of our high-growth companies. This effort will lead to much-needed resources that will help us grow our biotech industry, recruit new companies, and create valuable jobs for our local economy,” said Brett Malone, Ph.D., CEO of the VTCRC.

Image: https://www.vtcrc.com

Cursor and Notification Center

Visualized: Key Events in the COVID-19 Timeline It’s been a long and eventful year since COVID-19 was officially declared a global pandemic by the World Health Organization (WHO) on March 11, 2020.

The tangible and intangible costs of COVID-19 have been severe. In this visual COVID-19 timeline, we delve into some significant milestones that have occurred around the world.

 

NewImage

It is with immense gratitude and sincere best wishes that I announce National Center for Advancing Translational Sciences (NCATS) Director Christopher P. Austin, M.D. will be departing NIH. His last day will be April 15, 2021. After nearly a decade of bold leadership as the founding director of NCATS, Chris will become CEO-partner at Flagship Pioneering, a life science platforms company in Cambridge, Massachusetts.

Image: NCATS Director Christopher P. Austin, M.D.Daniel Soñé Photography, LLC

Stefanie-Tompkins

Stefanie Tompkins takes the reins today as the 23rd director of the Defense Advanced Research Projects Agency.

With nearly eleven years of DARPA service under her belt, Tompkins, a former military intelligence officer in the U.S. Army, has an exceptional understanding of the agency’s culture. From 2007 through 2017, she held multiple positions, including program manager and deputy director of the Strategic Technology Office, a systems-oriented technical office; DARPA chief of staff; and director of the Defense Sciences Office, a highly exploratory office that identifies and accelerates new technologies. In 2017 and into the beginning of 2018, she served as the acting deputy director of the agency.

 

Notification Center

As COVID-19 became a growing concern around the world early last year, Lauren Gardner tapped into her research expertise as an infectious disease modeler. Gardner, director of the Center for Systems Science and Engineering at Johns Hopkins University, along with her Ph.D. student, were motivated to create a dashboard to track the spread of the novel coronavirus. During a panel Tuesday at this year's virtual South by Southwest conference, she shared how the journey unfolded. 

Image: https://www.cnet.com/

NewImage

Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences companies through a SaaS-enabled digital marketplace and product platform, is announcing the appointment of Jennifer Main as chief operating officer (COO) and chief financial officer (CFO). On April 5, 2021, Ms. Main will join Amalgam Rx from Centers for Medicare and Medicaid Services (CMS) where she has served as COO, responsible for a wide range of functions, including financial management, information technology, acquisition, human capital, facilities, strategic planning, and enterprise risk management. Prior to that, she held senior executive titles, including that of CFO, in five different public and private organizations over the span of her 25+ year career. 

 

NewImage

Four Johns Hopkins professors have received grants for their research through the Bisciotti Foundation Translational Fund.

Established with a generous multiyear gift from the Stephen and Renee Bisciotti Foundation, the fund provides $300,000 annually in seed money to advance Johns Hopkins discoveries on a commercial path. Recipients are awarded from $25,000 and $100,000 to conduct their work during a period of up to nine months.

Image: The faculty winners of prizes from the Bisciotti Foundation Translational Fund are (clockwise from top left) Vivek Kumbhari, Xingde Li, Sung Hoon Kang, and Alan Cohen

Dr. Eric Edwards, co-founder and CEO of Richmond-based Phlow Corp.

Richmond-based Phlow Corp. announced Thursday the launch of a coalition that will help ensure that children’s hospitals across the country receive key medications. The Virginia Commonwealth University-affiliated Children’s Hospital of Richmond is one of 11 founding hospital members.

Children’s Hospital Coalition (CHC) aims to provide certainty in availability and access to medicine and address supply chain issues. Citing a 2019 survey of 330 American hospitals — including 29 children’s hospitals — Phlow says that medicine shortages disproportionately and uniquely impact children’s hospitals. The company also says that the pandemic has further exposed the vulnerabilities of the supply chain.

Image: Dr. Eric Edwards, co-founder and CEO of Richmond-based Phlow Corp.

NewImage

LONDON—The Oxford startup behind AstraZeneca PLC’s Covid-19 vaccine has raised $168 million in new funding, which it plans to use to adopt its vaccine technology for the treatment of other diseases.

The move is a step in Vaccitech Ltd.’s preparations for going public as soon as this year, according to people familiar with the plans. The moves were first reported by The Wall Street Journal.

Image: Royal Navy personnel administer the Oxford-AstraZeneca Covid-19 vaccine at a center in Bath, England. PHOTO: BEN BIRCHALL/ZUMA PRESS

Johnson and Johnson Innovation

Launching an innovative product or technology takes more than a good idea, and there are many actions startups can take to strengthen their offering and overall chance of success as they develop the latest innovations to bolster health security, including battling COVID-19. Over the last year, the global scientific community has proven critical to our collective ability to combat the pandemic, and BLUE KNIGHT™ offers a new way to build the kinds of partnerships needed to advance potentially life-saving technology during public health emergencies.

 

Handshake

Here are eight recent health IT vendor contracts and go-lives accelerating digital transformation efforts at healthcare organizations.

1. Highmark Health, the parent company of Pittsburgh-based Allegheny Health Network, is building upon its tech partnership with Google Cloud through a new six-year collaboration with the tech giant's sister company Verily. 

2. The Department of Veterans Affairs, in partnership with T-Mobile, is deploying 5G technologies to the Miami VA Healthcare System.

 

money

WASHINGTON, MARCH 19, 2021 – This week, U.S. Senators Chris Coons (D-Del.) and Dick Durbin (D-Ill.), both members of the Senate Appropriations Committee and Senate Competitiveness Caucus, reintroduced the Innovation Centers Acceleration Act, a bill which would expand research and development (R&D), targeted to reach a broader portion of the country. The legislation would complement a nationwide effort to compete with China economically by placing renewed emphasis on sectors key to economic resiliency and productivity, including biomedical technology, advanced manufacturing, and more.

 

keyboard

In March 2021, the Dutch government celebrates the start of Horizon Europe. Horizon Europe is the new European framework programme for research and innovation. During a series of online events, we will inform you about the possibilities within this large funding programme.

The National Contact Points from the Netherlands Enterprise Agency organise these events.

The series of events starts with an online kick-off event about the importance of Horizon Europe for the Netherlands. This event focusses on the policy aspects of the programme and is in Dutch. Find out more about the kick-off event (in Dutch).

 

Marina, Laurent and Rich

Marina Massingham, CEO, Aifred Health, and Laurent Waessa, Senior Business Development Advisor, Québec Government Office in New York, join BioTalk to discuss their backgrounds, Ecosystems for Entrepreneurs, and how Quebec can find partnerships in the BioHealth Capital Region

Listen via Apple http://apple.co/3lfW7q5, Google http://bit.ly/3qJm2HP, Spotify http://spoti.fi/30LaoSc, and TuneIn http://bit.ly/30JHq4Z.

SBIRXL6

Partnering meeting slots now are full with more than 450 1:1 partnering meetings requested with Program Officers from NSF, NIH and its individual institutes (NCI, NIA, NIAID, NIDA, NHLBI) and the University of Maryland MIPS.  Do not miss the opportunity to hear from these program leaders. Learn how to write compelling Research Aims and Commercialization Plans, current areas of focus for nondilutive funding resources, additional government resources, and best industry strategies to support your firm’s growth. Confirmed speakers/partnering meeting participants include:

  • Henry Ahn - Program Director, National Science Foundation (NSF)
  • Lynne Stein Benzion – Director, Economic Development, Montgomery County Econ. Dev. Corp. (MCEDC)
  • Katie Bratlie - Program Director, National Science Foundation (NSF)
  • Christie Canaria, PhD - Program Director, SBIR Development Center, National Cancer Institute (NCI)
  • Judy Costello – Managing Director, Economic Development, BioHealth Innovation (BHI)
  • Stephanie Davis, PhD - Small Business Program Coordinator, NIH Nat’l Heart Lung & Blood Inst. (NHLBI)
  • Sharon DisqueEconomic Development Manager, City of Gaithersburg, Maryland
  • Stephanie Fertig, HHS Small Business Program Lead, National Institutes of Health (NIH)
  • Jonathan Franca-Koh, PhD - Program Director, SBIR Development Center, National Cancer Inst (NCI).
  • Armineh Ghazarian - Senior Program Analyst, NIH National Institute on Aging (NIA)
  • Colleen Gibney, SBIR Deputy Project Manager, US Army Medical Research & Dev. Command (USAMRDC)
  • Luis Gutierrez - Entrepreneur-in-Residence, BioHealth Innovation, Inc. (BHI)
  • Todd Haim, PhD - Chief, Office of Small Business Research, NIH National Institute on Aging (NIA)
  • Elena Koustova, PhD, MBA - Director, Office of Translational Initiatives and Program Innovations (OTIPI), NIDA SBIR/STTR Coordinator, NIH National Institute of Drug Abuse (NIDA) Office of Director
  • Ashwin Kulkarni, COO, miRecule; Associate, BioHealth Innovation, Inc. (BHI)
  • Natalia Kruchinin, PhD SBIR/STTR Program Coordinator, RTSP, DEA, National Institute of Allergy and Infectious Diseases
  • Carla MerrittSenior Business Development Representative, Maryland Department of Commerce
  • JR Myers, SBIR Project Manager, US Army Medical Research & Development Command (USAMRDC)
  • Mike MinicozziPhD, Senior Program Officer, DAIT, National Institute of Allergy and Infectious Diseases
  • Alastair Monk - Program Director, National Science Foundation (NSF)
  • Deepa Narayanan - Program Director and Team Lead, NIH National Cancer Institute SBIR Development Center (NCI)
  • Rini Pek, PhD - Senior Analyst, BioHealth Innovation, Inc. (BHI)
  • Erik Pierstorff - Program Director, National Science Foundation (NSF)
  • Victor Prikhodko - Senior Business Dev. Mgr., SBIR/STTR NIH National Inst. of Drug Abuse (NIDA)
  • Monique Pond, PhD - Program Director, SBIR Development Center, National Cancer Institute
  • Reema Railkar, PhD Program Manager, SBIR Development Center, National Cancer Institute
  • Saroj Regmi, PhD - Health Science Administrator, Office of Small Business Research, NIH National Institute on Aging
  • Andrea Renner - Technical Assistance Advocate, US Army Medical Research & Dev Command (USAMRDC)
  • Ethel Rubin, PhD - Entrepreneur-in-Residence, BioHealth Innovation, Inc. (BHI)
  • Anthony Saleh, PhD – CEO, miRecule
  • Ben Schrag,PhD - Program Director, National Science Foundation (NSF)
  • John Sullivan - Entrepreneur-in-Residence, BioHealth Innovation, Inc. (BHI)
  • Onur UnalManager, Life Sciences Projects, Maryland Industrial Partnerships (MIPS), Maryland Technology Enterprise Institute (MTech), University of Maryland

 Register (no fee) today!    www.tinyurl.com/2021SBIR  Questions: This email address is being protected from spambots. You need JavaScript enabled to view it.
NOTE:  Different institutes are available to meet at different times during the March 17-19th period. 
              You will be able to request meetings once you have registered and received the partnering log-in.

Register Now!

Click here to view the agenda.

NewImage

 A free, virtual Forum focused on the growing Digital Health industry in the Baltimore/Washington region and beyond, presented by EAGB & BHI.

The Economic Alliance of Greater Baltimore (www.greaterbaltimore.org) and BioHealth Innovation (www.biohealthinnovation.org) have partnered to host a Forum focused on the growing Digital Health industry in the Baltimore/Washington region and beyond. The Forum is free and will be held virtually on March 25, from1 – 3:00 pm. There is no fee and all are welcomed, but you must register in order to receive the link to the event.

The Digital Health Forum features two panel discussions and a moderated conversation. Brief welcome comments by Rich Bendis and Michele Whelley, CEO of BHI and EAGB, respectively, will open the Forum.

  • PANEL ONE: The Role of Academia in Digital Health
  • PANEL TWO: Digital Health in Healthcare
  • CLOSING CONVERSATION: International Collaboration in Digital Health

Visit https://bit.ly/DigitalHealth21 to learn more and register for this FREE Event today.

Sponsored by: First National Bank, Olive, and TEDCO